Simvastatin

Análise de Custo-Efetividade da Sinvastatina versus Atorvastatina na Prevenção Secundária de Eventos Cardiovasculares no Sistema Único de Saúde Brasileiro

Brazil / Treatment Outcome / Risk assessment / Cardiovascular disease / Applied Economics / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin

Efeito do ramipril e da sinvastatina sobre o estresse oxidativo de ratos diabéticos

Nonparametric Statistics / Oxidative Stress / Antioxidants / Animals / Male / Medical Physiology / Rats / Analysis of Variance / Angiotensin Converting Enzyme Inhibitors / Simvastatin / Arquivos brasileiros / Medical Physiology / Rats / Analysis of Variance / Angiotensin Converting Enzyme Inhibitors / Simvastatin / Arquivos brasileiros

Análise de Custo-Efetividade da Sinvastatina versus Atorvastatina na Prevenção Secundária de Eventos Cardiovasculares no Sistema Único de Saúde Brasileiro

Brazil / Treatment Outcome / Risk assessment / Cardiovascular disease / Applied Economics / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin

Progenitor cell mobilizing treatments prevent experimental transplant arteriosclerosis

Polysaccharides / Hematopoietic Stem Cells / Mice / Animals / Vascular endothelium / Anticoagulants / Clinical Sciences / Molecular weight / Graft Rejection / Surgical / Aorta / Heterocyclic compounds / Simvastatin / Anticoagulants / Clinical Sciences / Molecular weight / Graft Rejection / Surgical / Aorta / Heterocyclic compounds / Simvastatin

Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Adolescent / Humans / Male / Young Adult / Bilirubin / Risk factors / Aged / Middle Aged / Adult / Cardiovascular Diseases / Biological markers / Risk Factors / Lipid / Simvastatin / Biochemistry and cell biology / Risk factors / Aged / Middle Aged / Adult / Cardiovascular Diseases / Biological markers / Risk Factors / Lipid / Simvastatin / Biochemistry and cell biology

Copyright © 2017 DADOSPDF Inc.